Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma-Reference-Cited by-同舟云学术

Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma

Published:2005-09 Issue:3 Volume:128 Page:1140-1145
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Jang An-Soo,Lee June-Hyuk,Park Sung Woo,Lee Young Mok,Uh Soo Taek,Kim Yong-Hoon,Park Choon-Sik

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Inhaled glucocorticoids for asthma;Barnes;N Engl J Med,1995

2. Issues in the use of inhaled glucocorticoids: The Asthma Clinical Research Network;Kamada;Am J Respir Crit Care Med,1996

3. National Asthma Education and Prevention Program. National Asthma Education and Prevention Program: expert panel report; guidelines for the diagnosis and management of asthma update on selected topics–2002;J Allergy Clin Immunol,2002

4. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma;Ward;Thorax,2002

5. High-dose inhaled steroid therapy for asthma;Toogood;J Allergy Clin Immunol,1989

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?;Pulmonary Pharmacology & Therapeutics;2022-12

2. Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma;Scientific Reports;2022-09-30

3. Quantitative comparison of dose–effect and time–course of fluticasone furoate and fluticasone propionate in adult and adolescent patients with persistent asthma: A systematic review and meta‐analysis;Respirology;2022-01-18

4. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients;Journal of Allergy and Clinical Immunology;2017-09

5. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation;Pharmacology & Therapeutics;2017-01